multiple-sclerosis

Comparison of statistical approaches dealing with time-dependent confounding in drug effectiveness studies

Estimating inverse probability weights using super learner when weight-model specification is unknown in a marginal structural Cox model context

On the application of statistical learning approaches to construct inverse probability weights in marginal structural cox models: hedging against weight-model misspecification

Comparison of statistical approaches for dealing with immortal time bias in drug effectiveness studies

Interferon beta and long-term disability in multiple sclerosis

Antibody dissociation rates are predictive of neutralizing antibody (NAb) course: A comparison of interferon beta-1b-treated Multiple Sclerosis (MS) patients with transient versus sustained NAbs

Beta-interferon exposure and onset of secondary progressive multiple sclerosis

Multiple sclerosis in older adults: the clinical profile and impact of interferon beta treatment

Investigation of heterogeneity in the association between interferon beta and disability progression in multiple sclerosis: an observational study

Marginal structural Cox models for estimating the association between beta-interferon exposure and disease progression in a multiple sclerosis cohort